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Abstract 
 SFME and HD for the extraction of essential oil in Lavandula officinalis in 
Alice have been reported. A total of 59 compounds were identified with the 
major compound being 1,8-cineole, an oxygenated monoterpene, with 
46.89% and 44.84% yield obtained for HD and SFME respectively. 
 Charge transfer (CT) complexes formed between α-pinene, 1,8-cineole 
and camphor as electron donors with iodine as the electron acceptor have 
been studied spectrophotometrically in methylene chloride solution.  The Be-
nesi-Hildebrand equation has been applied to estimate the formation con-
stant (Kf) and molecular extinction coefficient (εCT).  The value of Kf is the 
highest in camphor-I2 complex compared to the other two complexes. 
 Antibacterial assessment was carried out on the various reagents, deter-
mining the MIC of individual reagents and in combination.  The results show 
an improvement, on combination of the various reagents than when tested 
alone. 
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I. Introduction 
 Interaction means a kind of action that occurs when two or more objects 
have an effect upon one another.  In nature, substances interact one with 
another to give a product, which sometimes and in most cases have proper-
ties and characteristics, different from the initial substances coming togeth-
er. In this particular context, physico-chemical interaction refers to the 
charge-transfer formation between terpenes and oxygenated terpenes with 
some drugs.  The research is sequel to the honors  project work, where two 
isolation methods were employed and compared for the extraction of essen-
tial oil from Lavandula offinalis, in which a total of 59 compounds were iden-
tified with the major compound being 1,8-cineole, an oxygenated monoter-
pene, with 46.89% and 44.84% obtained for HD and SFME extraction tech-
niques, respectively.   
A. TERPENES 
 Terpenes are biogenic hydrocarbons present in large amounts in conifers 
and in smaller amounts in large variety of other plants (06MI1).  Structural-
ly, terpenes may be regarded as derivatives of isoprene (2-
methylbutadiene).  Monoterpenes (C10H16) predominate among the volatile 
terpenes.  Sesquiterpenes (C15H24), diterpenes (C20H32) and triterpenes 
(C30H48) have been identified in large numbers in plant material.  The chemi-
cal properties of the terpenes depend much on the presence of one or more 
olefinic double bonds in structure.  Terpenes are widespread in nature, main-
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ly in plants as constituents of essential oils. Many of them are hydrocarbons, 
but oxygen-containing compounds such as alcohols, aldehydes or ketones 
(terpenoids) are also found.  When terpenes are modified chemically by oxi-
dation or rearrangement of the carbon skeleton, the resulting compounds 
are generally referred to as terpenoids.  Terpenes and terpenoids are the 
primary constituents of the essential oils of many plants and flowers.  Essen-
tial oils are widely used as natural flavor additives for food, as fragrances in 
perfumery, and in traditional and alternative medicines such as aromathera-
py.  Examples of monoterpenes are α-pinene 1, β-pinene 2, limonene 3, ne-
rol 4, citral 5, 1,8-cineole 6, camphor 7, menthol 8, geraniol 9, and others. 
Examples of sesquiterpenes are nerolidol 10 or farnesol 11.  Examples of 
diterpenes are phytol 12 or vitamin A1 13. Squalene 14 is an example of a 
triterpene, and carotene (provitamin A1) 15 is a tetraterpene.   
CH2OH CHO
1 2 3 4 5  
O
O
OH
CH2OH
7 8 96  
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15  
 The terpenes used in this study are α-pinene 1, 1,8-cineole 6, and cam-
phor 7. 
1. α-Pinene 
 α-Pinene is an organic compound of the terpene class.  It is an alkene 
and it contains a reactive four-membered ring.  It is found in the oils of 
many species of many coniferous trees, notably the pine.  It is also found in 
the essential oils of rosemary (Rosmarinus officinalis) and lavender (Lavan-
dula officinalis).  It is a monoterpene that may be a significant factor affect-
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ing bacterial activities in nature.  It is a clear, colorless liquid with the mole-
cular formula C10H16, having the molar mass of 136.23 g/mol. It has a very 
low solubility in water. 
 α-Pinene is a very reactive reagent as a result of its four-membered ring.  
The reactivity of α-pinene is described in Scheme 1. The four-membered ring 
in α-pinene makes it a reactive hydrocarbon, prone to skeletal rearrange-
ments such as the Wagner-Meerwein rearrangement.  Wagner-Meerwein 
rearrangement is a class of carbocation 1,2-rearrangement reactions in 
which a hydrogen, alkyl or aryl group migrates from one carbon to a neigh-
boring carbon (00JCE858).  A carbocation is an ion with a positively-charged 
carbon atom.  Such a structure 16 plays the role of reactive intermediates in 
many organic reactions. Wagner-Meerwein rearrangement was first discov-
ered in bicyclic terpenes, for example (Scheme 2), the conversion of iso-
borneol to camphene (07MI1). 
H
C
H H
16  
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2. 1,8-Cineole 
 1,8-Cineole, 6, the monoterpene cyclic ether known as eucalyptol, is one 
of the components in essential oils from Lavandula officinalis. It is a terpeno-
id oxide present in many plant essential oils and it was found to display an 
inhibitory effect on some types of inflammation in rats (00PR240). This com-
ponent has a characteristic fresh and camphoraceous fragrance and pungent 
taste and is used for pharmaceutical preparations as an external applicant, a 
nasal spray, a disinfectant, an analgesic, or a food flavoring.  It is also used 
for cosmetics.  Furthermore, it has been reported that 1,8-cineole is used to 
treat cough, muscular pain, neurosis, rheumatism, asthma, and urinary 
stone (55RIC577, 99MI1).  Although it can be used internally as a flavoring 
and medicine ingredient at very low doses, eucalyptol is toxic if ingested at 
higher than normal doses (MSDS).  Eucalyptol forms crystalline adducts with 
halogen acids, o-cresol, resorcinol, and phosphoric acid.  Formation of these 
adducts are useful for purification.  Cineole-based eucalyptus oil is used as a 
flavoring at low levels (0.002%) in various products, including baked goods, 
confectionery, meat products, and beverages (01MI1).  Eucalyptol is used as 
an insecticide and insect repellent (87JEC2131). 
3. Camphor 
 Camphor 7 is a waxy, white, or transparent solid with a strong, aromatic 
odor (94MI1).  It is a terpenoid with the chemical formula C10H16O.  It was 
found in the wood of the camphor laurel (Cinnamomum camphora), a large 
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evergreen tree found in Asia. Camphor can be produced from α-pinene, 
which is abundant in the oils of coniferous trees and can be distilled from 
turpentine.  It is used an insect repellent, in the manufacture of films, plas-
tics, lacquers, explosives, and in medicine, mainly in external preparations 
to relieve mild pain and itching. 
4. Drugs 
 Drugs are substances of natural or synthetic origin, which can alter the 
emotional state, perception, body functioning or behavior of an organism.  
They are substances used to treat or prevent diseases, relieve pains, control 
mental or physical ailments and to help diagnose illnesses.  Broadly speak-
ing, it is any substance which, when absorbed into the body of a living or-
ganism, alter normal bodily function (69WHO1).  In pharmacology, a drug is 
“a chemical substance used in the treatment, cure, prevention, or diagnosis 
of disease or used to otherwise enhances physical or mental well-being” 
(07MI2).   Without drugs, many people would not live as long as they do or 
enjoy life from diseases and pains. The drugs that are referred to in this 
study are betadine (iodine-based), resorcinol (a polyphenol distributed in 
South Africa as eskamel) and colloid silver modeled as silver perchlorate in 
this work.  All these have been proven to be active as antiseptics or bacteri-
cides.   
 In one way or another, many of us have probably used an iodine-based 
disinfectant to clean a minor skin wound. Betadine cream is a brand of con-
25 
 
sumer-available povidone-iodine topical antiseptics.  It is used in treating 
minor wounds and infections, as well as killing bacteria.  It is an antiseptic 
combination, working by killing sensitive bacteria.  The ointment involves a 
stable complex of polyvinylpyrrolidone (povidone) and elemental iodine 17 
(11SP79).  It contains from 9.0% to 12.0% available iodine, calculated on a 
dry basis. 
N O
H+
O N
I3
-
CH2 CH CH2 CH CH2 CH
N O
n m
17  
Free iodine, slowly liberated from the povidone-iodine complex in solution, 
kills eukaryotic or prokaryotic cells through iodination of lipids and oxidation 
of cytoplasmic and membrane compounds.  This agent exhibits a broad 
range of microbicidal activity against bacteria, fungi, protozoa, and viruses. 
Slow release of iodine from the complex in solution minimizes iodine toxicity 
towards mammalian cells.  The Betadine used was purchased in one of the 
local pharmaceutical shop in the University of Fort Hare environment. 
 Resorcinol (or resorcin) 18 is a dihydroxybenzene.  It is the 1,3-isomer of 
benzenediol with the formula C6H4(OH)2.  It is a white crystalline compound 
with a weak odor and a bittersweet taste (00MI1). Resorcinol can be re-
garded as a phenol derivative in which a hydrogen atom is substituted by a 
hydroxyl group in the meta-position with respect to the OH. 
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HO OH
18  
Resorcinol exists in at least two crystalline modifications (phases).  At nor-
mal pressure, the α-phase is stable below about 71°C, whereas the β-phase 
is stable above that temperature up to the melting point (00MI1).  Crystal-
line resorcinol is hygroscopic.  The water solubility data indicate that resorci-
nol is almost completely miscible in water. Resorcinol is an important chemi-
cal intermediate in the manufacture of specialty chemicals, such as hexylre-
sorcinol, p-aminosalicylic acid, and light screening agents for the protection 
of plastics from exposure to UV light.  Other uses include the manufacture of 
dyestuff, pharmaceuticals, flame retardants, agricultural chemicals, fungicid-
al creams and lotions, explosive primers, antioxidants, a chain extender to 
urethane elastomers, and a treatment to improve the mechanical and chem-
ical resistance of paper machine fabrics (00MI1).  Resorcinol is used in 
pharmaceutical preparations for the topical treatment of skin conditions such 
as acne, seborrhoeic dermatitis, eczema, psoriasis, corns, and warts. An 
emerging use of resorcinol is as a template molecule in supramolecular che-
mistry.  The –OH groups on resorcinol form hydrogen bonds to target mole-
cules holding them in the proper orientation for a reaction.  Many such reac-
tions are able to be carried out in the solid state thereby reducing or elimi-
nating the use of solvents that may be harmful to the environment. 
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 Silver perchlorate is a chemical compound with the formula AgClO4, 19.  
It is a white solid, forms a monohydrate, and is mildly deliquescent.  It is a 
source of the Ag+ ion, although the presence of perchlorate presents risks. 
O
O O-
O
Cl Ag+
19  
 Silver ions and silver compounds show a toxic effect on some bacteria, 
viruses, algae and fungi, typical for heavy metals like lead or mercury, but 
without the high toxicity to humans that are normally associated with these 
other metals.  Its germicidal effects kill many microbial organisms in vitro, 
but testing and standardization of silver products is difficult (07JAC987).  
Silver is widely used in topical gels and impregnated into bandages because 
of its wide-spectrum antimicrobial activity.  The anti-microbial properties of 
silver stem from the chemical properties of its ionized form, Ag+.  This ion 
forms strong molecular bonds with other substances used by bacteria to res-
pire, such as molecules containing sulfur, nitrogen, and oxygen (92LM72).  
When the Ag+ ion forms a complex with these molecules, they are rendered 
unusable by the bacteria, depriving them of necessary compounds and even-
tually leading to the bacteria’s death.  Silver perchlorate is used to model 
the effects of colloidal silver, a well-known bactericide, antiseptic, and anti-
microbial agent.  
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 This research work centers on investigating the charge-transfer complex-
ation between iodine and various donor compounds spectrophotometrically 
in dichloromethane, interactions of the donors with phenol by hydrogen 
bonding as well as formation of the molecular complexes with silver perchlo-
rate.  Extensive work has been done on the charge transfer complexation 
with iodine and various donor compounds.  Very little work has been done 
on charge transfer complex formation involving iodine and pure compounds 
from essential oil, acting as the electron donors. 
5. Objectives of the research 
 To determine and analyze the various chemical components of lavender, 
using two different extraction techniques, hydrodistillation and solvent-free 
microwave extraction and, identifying the oil components, using GC-MS. 
 To study the charge transfer complexation, spectrophotometrically be-
tween iodine and major extracted components α-pinene, camphor, and 1,8-
cineole, including stability constants of the complex and kinetics of complex 
formation.  
 To study the hydrogen bonding formation between phenol and aforemen-
tioned components of the medicinal plant essential oils including evaluation 
of the basic thermodynamic functions ∆H°, ∆S° and ∆G°, determination of 
the stability constants. 
 To synthesize and characterize solid complexes of α-pinene, camphor, 
and 1,8-cineole with silver perchlorate. 
29 
 
 To assess the antimicrobial activities of α-pinene, camphor, and 1,8-
cineole on interaction both with model substances (molecular iodine, phenol, 
resorcinol, and silver perchlorate) and with betadine, eskamel, and colloidal 
silver in order to assess whether the effect of their interactions is antagonis-
tic, synergistic, or indifferent on tested bacteria. 
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II. Review of Literature 
A. LAVANDULA OFFICINALIS 
 Africa, and especially Southern Africa, has a rich diversity of plants.  Re-
cent statistics show that about 25% of the total number of higher plants in 
the world is found in Africa south of the Sahara. According to the African 
plant checklist and database project (06MI2), a total of 50,136 angiosperm 
taxa occur in tropical Africa and southern Africa. This figure is based on a re-
cent merging of two major data bases EPFAT (Enumeration des plantes a 
fleurs d ’Afrique) and FSA (Flora of Southern Africa). The combined checklist 
shows a total of 32,424 taxa in tropical Africa and 22,755 taxa in southern 
Africa. A useful reference book on the medicinal plants of the whole African 
continent (00MI2) lists more than 5,400 medicinal plant taxa and over 
16,300 medicinal uses. About 3,000 medicinal plants are regularly used in 
southern Africa (00MI3, 05JEP127). An annotated checklist of traditional 
medicinal plants of southern Africa (02MI1) gives a total of 3,481 plant taxa, 
of which 2,942 are administered to people only. 
 One of such plants that found its use in medicinal and household use is 
Lavandula officinalis (Fig. 1). Known as the true lavender, other synonym for 
this species is Lavandula angustifolia. Lavandula officinalis is a flowering 
plant in the family Lamiaceae, primarily in the Pyrenees and other moun-
tains in northern Spain.  The thin, lanceolate leaves have a characteristic 
grey-green color. When touched, the leaves emit an aromatic, pleasant fra-
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grance. However, the plant is best known for the fresh fragrance of its flow-
ers, which bloom with 6 to 10 blossoms on terminal spikes. Lavandula is 
probably reference to its use as an alternative to bathing; angustifolia means 
narrow leaf. Cosmetic and therapeutic applications of lavender date back at 
least to the time of the ancient Greek (00MI4, 00MI5).  It is one of the most 
useful medicinal plants.  Commercially, lavender, as it is normally called, 
provides several important essential oils to the fragrance industry, including 
soaps, colognes, perfumes, skin lotions and other cosmetics (04JEO347).  In 
food manufacturing, lavender essential oil is employed in flavoring beverag-
es, ice cream, and candies, baked goods and chewing gum (02JC(A)31).  
Recently, aromatherapy has become increasingly popular, and lavender is 
used in aromatherapy as a relaxant (99PM700, 99PR540).  Many members 
of the botanical family Lamiaceae produce considerable amount of essential 
oils. Within this family, the genus Lavandula comprises 30 known species 
among which three are economically important: Lavandula angustifolia, La-
vandula latifolia, and the hybrid lavandin L. angustifolia x L. latifolia.  The 
essential oil of the highest quality is distilled from the flowering tips of L. an-
gustifolia, the true lavender, and its characteristics scent has been prized 
since ancient times. Lavender is regarded as a pharmaceutical plant with 
predominantly sedative effects employed in aromatherapy (07ABB417). 
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Figure 1: Lavandula officinalis 
1. Chemical constituents and various uses of Lavandula officinalis 
The chemical composition of lavender essential oil depends largely on the 
species from which it was obtained (69SPC883, 75PAH373). Within the same 
species, the biochemical contents of the essential oil found in the flowers, 
stem, or leaves differs significantly depending on where and under what 
conditions the plant was grown (87PC995,  96PGR277). The presence and 
concentration of certain chemical constituents also fluctuates according to 
the season (95FFJ93) and the maturation of the plant when harvested 
(97AP133). Even the extraction process used to collect the oil introduces 
variation in the concentrations of biochemical compounds present in the dis-
tillate. Steam-distilled extracts have a characteristically higher ratio of α-
terpineol and linalool to linalyl acetate compared to supercritical fluid ex-
tracts (95JAF1654, 96FFJ157, 06ACA157).  Burning lavender oil does not af-
fect its composition, implying that inhaling smoke from lavender aromathe-
rapy candles may have the same impact as inhaling the vapor of the un-
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heated essential oil (93JPS660). The outline below shows the potentially ac-
tive chemical components in lavender (10JC(A)1530): 
• Monoterpenes: α-pinene, β-pinene, β-ocimene, camphene, limonene, 
p-cymene, sabinene, terpinene. 
• Monoterpene alcohols: α-terpineol, borneol, lavandulol, linalool, p-
cymen-8-ol, trans-pivocarveol. 
• Monoterpene aldehydes: cumin aldehydes 
• Monoterpene ethers: 1,8-cineole (eucalyptol) 
• Monoterpene esters: linalyl acetate, terpenyl acetate 
• Monoterpene ketones: carvone, coumarin, cryptone, fenchone, me-
thylheptenone, n-octanone, nopinone, p-methylacetophenone 
• Benzenoids: eugenol, coumarin, cavacrol, hydroxycinnamic acid, ros-
marinic acid, thymol. 
• Sesquiterpenes: caryophyllene, caryophyllene oxide, α-photosantanol, 
α-norsantalenone, α-santalal. 
Trace components of many other compounds, such as flavonoids, have been 
identified (86FT199, 97AP133, 04PF53). 
 Although the chemical composition of the oils is complex, the biological 
activities of some of the major chemical species present have been eva-
luated. Linalyl acetate and linalool have sedative (91ZN(C)1067, 98ACA93) 
and local anesthetic effects (99PM700).  Linalool also has antibacterial 
(88PRC77, 97MB39, 99LAM130), antifungal (97MB39, 98JAF1739), and in-
34 
 
secticidal (88JME1, 98RNM178) effects. These two compounds are the most 
prominent chemical constituents in the essential oil of L. angustifolia, ac-
counting for up to 90% of the oil by volume (84PF53, 94MI2).   Linalool also 
comprises over 70% of the essential oil of L. hybrid, a species commonly 
used by the perfume and pharmaceutical industries (89HH37, 93NT32).  
Relative concentrations of linalyl acetate and linalool are lower in L. latifolia 
(99USP24), and their concentrations range as 5–70% in L. dentate 
(76PH650, 84PF53, 90PH69).  Following topical application of the essential 
oil of L. angustifolia, linalyl acetate and linalool can be detected in the blood 
within 5 minutes, peak at 19 minutes, and are cleared within 90 minutes 
(75FCT653, 92JSC49).  They are also detected in the blood following inhala-
tion of lavender oil (90FJA922, 91ZN(C)1067) and in exhaled air following 
massage (91JCEL499, 04EC30, 05SPH27). 
 1,8-Cineole has antispasmodic (90PH69) and antifungal (94PC139, 
97MB39) properties. It comprises over 50% of the essential oil of L. dentate 
(84PF53, 91BMS801). 1,8-Cineole has also been detected in L. angustifolia, 
L. latifolia, and L. hybrida, although in much lower concentrations 
(69SPC739, 94FFJ11, 94MI2). Eugenol also has spasmolytic activity 
(84AOB611), as well as local anesthetic effects (84AOB611, 91AN137, 
99PM700).  The antibacterial properties of L. angustifolia have partially been 
attributed to the action of eugenol, which is also found in L. latifolia 
(69SPC739, 97JAC305) and in rosmarinic acid (99JAF2937), and it has also 
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been detected in L. hybrida (94MBI809). Other constituents of lavender with 
antibacterial effects include α-terpineol and terpene-4-ol, found in L. den-
tate. L. latifolia and L. hybrida (69SPC739, 90P69, 97AP133), and camphor 
present in each but found in high concentrations in L. latifolia compared to 
the other varieties (69SPC739).  α-Pinene, 1,8-cineole, β-pinene, and p-
cymene have some antifungal activity (98FFJ98, 98JAF1739).  Terpineol, α-
pinene, and camphene have anti-lice activity (98RNM178). Coumarin found 
in L.angustifolia, L. latifolia and L. dentate (79PH564, 84PF53, 94MI2) and 
caryophyllene oxide found in L. latifolia and L. angustifolia (84PF53, 94MI2) 
have anti-inflammatory effects (90CPB2283). 
 A total of 59 compounds were identified in the leaves of Lavandula offici-
nalis, growing in Alice, Eastern Cape, South Africa, with the major being 1,8-
cinole, an oxygenated monoterpene, with 46.89% and 44.84% obtained for 
HD and SFME respectively.  The chemical constituents of the essential oil of 
flowers of Lavandula officinalis growing in Isfahan, Iran, found using TLC and 
gas chromatography-mass spectrometry (GC-MS) methods, include 12 com-
ponents constituting 94.8% of the examined oil: linalool (34.1%), 1,8-
cineole (18.5%), borneol (14.5%), camphor (10.2%), terpineol (4.5%), li-
nalyl acetate (3.7%), α-bisabolol (3%), α-terpineol (2.2%) and (Z)-β-
farnesen (2.2%). 
 The data on chemical composition of lavender in various countries (Table 
1) show a diversity of different components. In most cases, linalool is the 
36 
 
principal component, including lavender collected in Pakistan (11PJB1315). 
However, fenchone, 1,8-cineole, and pinene types occur in some cases. 
Table 1: Chemical Composition of Lavender Samples Collected in Various 
Countries 
Component Percentage 
Method of ex-
traction 
Country Reference 
Borneol 
1,8-Cineole 
11.3 
25.7 
HD Iran 11AJB196 
1,8-Cineole 
Linalool 
Camphor 
Borneol 
18.5 
34.1 
10.2 
14.5 
HD Iran 06IJP169 
1,8-Cineole 
Linalool 
Camphor 
Borneol 
7.23 
47.8 
11.8 
4.15 
MASD France 06ACA157 
1,8-Cineole 
Linalool 
Camphor 
Borneol 
7.29 
46.9 
10.2 
4.07 
SD France 06ACA157 
1,8-Cineole 
Fenchone 
Camphor 
Virdiflorol 
8.71 
37.5 
17.1 
7.38 
HD Algeria 11CB937 
α-Pinene 
β-Pinene 
1,8-Cineole 
Linalool 
Pincarveol 
8.38 
30.1 
5.47 
4.46 
8.59 
HD Morocco 10WJC103 
Sabinene 
1,8-Cineole 
13.89 
41.28 HD Morocco 09IJA113 
Linalool 
Linalyl acetate 
26.9 
22.8 
HD Greece 10ICP 
1,8-Cineole 
Camphor 
α-Pinene 
Linalool 
34.6 
13.4 
9.00 
7.90 
HD Portugal 11JMM 
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B. CHARGE-TRANSFER COMPLEXES 
A charge-transfer complex is any aggregate (containing two or more mo-
lecules, molecular entities, or functional groups) in which an electric charge 
is transferred from a donor to an acceptor.  The concept of charge-transfer 
was introduced by Mulliken (52JPC801) as a description of complex forma-
tion in which new electronic absorption bands, attributable to neither the do-
nor, nor the acceptor is observable. The formation of electron donor-
acceptor (EDA) charge-transfer complexes between two molecules involves 
the transfer of an electron from the highest occupied molecular orbital (HO-
MO) of the donor to the lowest unoccupied molecular orbital (LUMO) of the 
acceptor (98MJ175).  Charge–transfer complexes are molecular complexes 
formed by the weak interaction between electron donors and electron accep-
tors.  An electron donor may be defined as a molecule possessing a relative-
ly high localized electron density.  Conversely, an electron acceptor is rela-
tively deficient in electrons. Charge-transfer complexes are also termed elec-
tron donor-acceptor complexes. In electron donor-acceptor complexes, there 
is always a donor and an acceptor molecule.  The donor may donate an un-
shared pair (an n-donor) or a pair of electrons in a  π orbital of a double 
bond or aromatic system (a π donor). One of the tests for the presence of an 
EDA complex is the electronic spectrum. These complexes generally exhibit a 
spectrum (called a charge transfer spectrum), which is not the same as the 
sum of the spectra of the two individual molecules.  Because the first excited 
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state of the complex is relatively close in energy to the ground state, there is 
usually a peak in the visible or near-UV region, and electron donor-acceptor 
complexes are often colored.  These charge transfer complexes have unique 
absorption bands in the ultraviolet-visible region. The compositions of donor-
acceptor complexes could not be isolated at ordinary temperatures in pure 
state since they are mostly unstable. However, they exist only in solutions in 
equilibrium with their components. The rates of formation of complexes in 
solution are generally so rapid that kinetic studies of the reactions cannot be 
made, at least by ordinary procedures. The values of heat of interaction are 
generally smaller than the forces of coordination and are much feebler than 
those established in the formation of covalent bonds (64MI1). That is, the 
degree to which electron transfer from the donor component to the acceptor 
component takes place is much less than that ordinarily occurs when new 
compounds are formed (52JPC801).  Aromatic hydrocarbons are rich in π-
electron and favor the formation of charge-transfer complexes with electron 
deficient molecules. This may be the due to the intermolecular attractive 
forces or through dipole-dipole interaction with electron deficient molecules. 
Charge-transfer complexes exist in two states: a ground state and an ex-
cited state. In the ground state, the two molecules composing the complex 
undergo the normal physical forces expected between two molecules which 
are in close proximity to each other. These include London dispersion forces 
and any electrostatic interactions, such as between dipole moments.  In ad-
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dition, a small amount of charge is transferred from the donor to the accep-
tor.  This contributes some additional binding energy to the complex 
(71MI1).  The excited state of the complex occurs when the ground state 
complex absorbs a photon of light having appropriate frequency. In the ex-
cited state, the electron which had only been slightly shifted towards the ac-
ceptor in the ground state is almost totally transferred. Depending on the 
structural features of both the donor and acceptor, the wavelength of light 
absorbed may be in the visible range of the electromagnetic spectrum. In 
many cases, therefore, charge-transfer complexes are colored substances.  
Examples of such charge-transfer complexes include the complex formed be-
tween a metal ion and a π orbital of a double bond or an aromatic system 
(73CRV163, 76ADOC33), the complex formed between polynitro aromatics, 
such as picric acid (62RCR8) as well as n-orbital-containing molecules, and 
complexes of I2 and Br2 with amines, ketones, aromatics, etc. Phenols and 
quinones also form charge-transfer complexes (74MI1). 
The ground state of the complex is described by the wave function, ΨN, 
which is the hybrid of two wave functions, ψ(A, D) and ψ(A-D+) (69MI2).  
The wave function ψ(A,D) is termed as the no-bond function and represents 
the wave function of the two molecules in close proximity to each other but 
with no charge-transfer between them.  Ψ(A, D) may include, however, the 
normal electrical interactions between molecules.  Consequently, the ground 
state wave function for a weak complex can be described as: 
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ΨN   =   aΨ(A,D)   +   bΨ(A-D+) 
Here a>>b. The wave function Ψ(A-D+) is called the dative function and 
represents two molecules held together by total transfer of an electron from 
the donor, D, to the acceptor, A.  The excited state of the complex can then 
be described by: 
ΨE = b*Ψ(A-D+) - a*Ψ(A,D)                                    
Here b*>>a*. 
Charge transfer complexes may conveniently be classified according to 
the types of orbitals in the donor and acceptor molecules which are under-
going the interaction. Donor and acceptor molecules may each be divided in-
to three classes (03MI1), as shown in the Table 2 below.  The ν-acceptors 
refer to metal atoms possessing a low-lying vacant valence-orbital.  Hypo-
thetically, there are nine possible types of complexes.  However in practice, 
the n-donors do not form complexes with metal ions but form covalent 
bonds instead (07MI3). 
Table 2: Charge-Transfer Complexes: Donor and Acceptor Types 
 Donor type   Examples 
         σ     R-X, cyclopropane 
         n    R2O, R3N, pyridine, dioxane 
π Aromatic and unsaturated hydrocarbons, especially if 
containing electron releasing substituent (hexamethyl-
benzene or phenols) 
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 Acceptor type  Examples 
         ν    Ag+, certain organometalics 
         σ    I2, Br2, ICl 
π Aromatic and unsaturated hydrocarbons, especially if 
containing electron withdrawing substituents (TCNE, ha-
logenated quinones). 
π-Donors include alkenes, alkynes, aromatic hydrocarbons and their subs-
titution products. The adducts which they form are called π-complexes. Here 
the electron transfer takes place when a π-donor coordinates with an accep-
tor. The term ‘outer complex’ has also been used (52JPC801) in describing 
adducts of this kind to emphasize that the acceptor does not make deep pe-
netration into the π-orbital. 
n-Donors include a large group of substances in which there are non-
bonded electrons (lone pairs) available for coordination. Alcohols, organic 
iodides and nitrogen bases are examples. 
Complexes of a wide variety of inorganic acceptors have been reported 
(61MI1).  Some of this type of acceptors include chlorine, bromine, iodine, 
iodine monochloride, oxygen, salt of copper (I), silver (I), and mercury (II), 
aluminum bromide and hydrogen halides. 
π-Acids and other organic acceptors embrace a variety of organic com-
pounds which function as dienophiles in the Diels-Alder reaction, such as 
ethylene with highly electronegative substituents, chloranil. Tetracyanoethy-
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lene, polynitro aliphatic and aromatic substances, tetranitromethane in very 
dilute solution, nitrobenzene, 2,4,7-trinitrofluorenone, and 1,3,5-
tricyanobenzene are some of the acceptors.  Iodine, bromine, or even chlo-
rine accepts electrons from both n-donors and π-donors.  Such complexes 
are formed with amines, aromatic hydrocarbons, ketones, etc.  This is the 
reason why iodine is not its normal purple color in solvents such as acetone, 
ethanol, and benzene.  IBr and ICl also form complexes, in which the iodine 
end of the molecule is the acceptor (65ACS807). 
Charge-transfer complexes can exist as intermolecular complexes, where 
the interaction takes place between two molecules, or as intramolecular 
complexes, where both the donor and acceptor moieties are contained within 
one molecule.  For the charge-transfer interaction to occur, the donor and 
acceptor components must be close enough, for their differences in electron 
density to be felt.  For unrestrained complexes, distance between the com-
ponents of 3.0-3.4 Ǻ, or slightly less than the van der Waals’ distance, are 
common (71MI1). 
Most charge-transfer complexes exist in a 1:1 stoichiometric ratio of do-
nor to acceptor.  For some π-π types of complexes, there is evidence for the 
existence of higher order complexes in equilibrium with the 1:1 complexes 
(80JPC2135).  For the 2:1 complex involving two donors, D2A, support has 
been found for the D-A-A form rather than the D-D-A form. The crystal 
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structures of phenol-benzoquinone complexes have been found to have both 
1:1 and 2:1 stoichiometries (69MI1).    
The occurrence of a charge-transfer usually requires some amount of 
overlap between the molecular orbitals of the donor and acceptor.  Normally, 
the interaction is between the highest occupied molecular orbital (HOMO) of 
the donor with the lowest unoccupied molecular orbital (LUMO) of the accep-
tor. This overlap principle is certainly true for intermolecular complexes.  
However, for intramolecular complexes, examples are also known of indirect, 
through-bond interactions, besides the direct, through-space interactions 
(77AGE799, 82JA5127). 
The amount of orbital overlap between the donor and acceptor plays a 
critical role in the magnitude of the charge-transfer interaction observed.  
Constraints resulting from steric hindrances are major factors in this regard.  
For instance, the binding energies for the charge-transfer complexes be-
tween phenol and hydroquinone with p-benzoquinone were found to be larg-
er than those for anisol and hydroquinone dimethyl ether with p-
benzoquinone (55JA2644). This was attributed to the steric influence of the 
methyl groups.  For highly substituted molecules, steric hindrance may well 
prevent the close approach necessary in order for charge-transfer interac-
tions to take place.  For most complexes, however, the charge transfer con-
tribution to the complex stability appears to be minor or negligible, and 
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these complexes may be considered to be non-covalently bound, despite 
their possession of intense electronic absorption spectra.  
C. HYDROGEN BONDING 
This is the second class of specific interactions to be considered in this 
study.  It occurs during the complexation of phenol with the various pure 
compounds (terpenes) under study.  Hydrogen bonds are a type of electros-
tatic interaction which arises from dipole-dipole interactions between a 
weakly acidic donor group and an acceptor group that bears a lone pair of 
electron (04MI1).  The absolute importance of hydrogen bonding in the de-
scription of a large number of chemical and biological systems cannot be de-
nied.  Although the hydrogen bond is not a particularly strong bond, it has a 
great significance in determining the properties of substances. As such, sev-
eral reports and reviews of the fundamental nature of this important bonding 
mechanism have been performed (59MI1, 60MI1, 60MI2, 71MI2, 91MI1).  
These intermolecular interactions govern many important processes, such as 
the base pairing of DNA and secondary structure of proteins, and have great 
influence over the bulk properties of many substances, such as the high boil-
ing point of water.  Scientists have been looking at hydrogen bonding inte-
ractions dating back to the 1920s when the hydrogen bonding phenomenon 
in water using varying temperatures was postulated.  Pauling later post-
ulated that hydrogen bonding is fairly ionic in nature and forms between on-
ly the most electronegative atoms.  He then mentioned the fact that hydro-
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gen bonding is of great importance in the determination of properties of sub-
stances and today, we can bear witness to this statement.  Pimentel and 
McClellan defined a hydrogen bond between a functional group A-H and an 
atom, or a group, B in the same or different molecule when there is evidence 
of bond formation, be it association or chelation, there is evidence that this 
new bond linking A-H and B specifically involves the hydrogen atom already 
boded to A. This definition fails to account for the chemical nature of the 
participants, including the polarities, and net charges are equally unspeci-
fied.  The definition has no restrictions on the interaction geometry; it simply 
makes the assumption that a hydrogen atom must be involved. 
Steiner (02AGE48) later gave a definition of hydrogen bonding, stating 
the following: An A-H⋅⋅⋅B interaction is called a hydrogen bond, if it consti-
tutes a local bond, and A-H acts as a proton donor to B. This definition has 
been widely accepted as the general definition for hydrogen bonding as it 
addresses the acid/base properties of A-H (donor) and B (acceptor), which in 
principle can be understood by the incipient proton-transfer reaction from A-
H to B.  In a particular hydrogen bond, A-H⋅⋅⋅B, the group A-H is called the 
proton donor and B is called the proton acceptor. Some authors refer to it as 
electron-acceptors and electron-donors.  The nature of single hydrogen 
bonds has been examined for many simple systems which contain only one 
hydrogen bond donor and acceptor.  There has also been exploration of the 
hydrogen bond donor and acceptor capabilities of various chemical functional 
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groups and their dependence on upon neighboring functional groups within a 
molecule (02PCCP490). 
Hydrogen bonds are relatively common in chemistry, and occur when a 
hydrogen atom is bonded to an electronegative or electron deficient atom 
and is in close proximity to an acceptor atom which is electron rich.  Hydro-
gen bonds are defined as the sharing of the hydrogen nucleus, or proton, 
between the donor and acceptor.  Hydrogen bonds typically have strengths 
in the range of 5-50 kJ mol-1 (02ACR565), which is significantly less than a 
covalent bond. Thus energy of specific interaction of α-pinene with phos-
phorylated nucleocapsid protein is 8.8 kJ mol-1 (11MOL1044). Hydrogen 
bonding between 2-phenylethanol and α-pinene or camphor was studied 
photophysically (99JPC(A)1991). 
The hydrogen bond has been widely investigated by spectroscopic tools 
such as IR and NMR spectroscopy and neutron/X-ray diffraction.  Figure 2 
shows the main types of hydrogen bonds which have been characterized 
(00MI6).  The strength of a hydrogen bond can vary from the weakest (~4 
kJ/mol) to the strongest (~120 kJ/mol) in intermolecular non-covalent inte-
ractions, depending on the interaction direction. 
 For the hydrogen bonding between phenols and cyanides and the shifts 
of the bonded OH group frequency were determined for a range of cyanides 
(66PRCL460).  Equilibrium constants for the formation of the complexes 
were equally determined and correlated with the frequency shifts.  In find-
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ings, the C≡N group frequency is displaced to higher frequency when 
bonded to phenol.  This effect was thought to be unusual, suggesting that 
the bonding occurs through the lone pair electrons on the nitrogen atom. 
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Figure 2: Main Types of Hydrogen Bond Geometry 
The possibility and extent of the hydrogen bond formation between vari-
ous substituted phenols and p-benzoquinone and chloranil (09AJP72) were 
investigated by FT-IR spectroscopy.  A conclusion was reached that there is 
weak hydrogen bonding between the different types of phenol with p-
benzoquinone and chloranil respectively, since the extent of lowering of fre-
quency in the formation of hydrogen bonds indicates the strength of the 
bonds.  It was also established that there is a complexation between phenols 
and quinines via weak hydrogen bonding. 
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D. SILVER PERCHLORATE COMPLEXES 
The usefulness of silver as an antimicrobial agent has been known for a 
long time.  It is an effective agent with low toxicity, which is especially im-
portant in the topical antibacterial treatment of burn wounds, where tran-
sient bacteremia is commonly cited (97JT1066).  Silver sulfonamides, par-
ticularly silver sulfadiazine (94JBC213), have been used as the standard 
treatment for burns, either alone or in combination with other antibiotics 
(88JBC359), cerium (77SGO668), and zinc compounds (90JBC112).  It was 
suggested that the basic function of the almost insoluble silver sulfadiazine 
may be the slow release of silver into the superficial wound environment 
(70AS281).  The application of silver-binding membranes has recently been 
suggested to further reduce the likelihood of silver toxicity to retard the 
movement of silver ions and minimize silver absorption at a healing wound 
(97CLC43, 00JB117).   
Silver compounds are used as disinfectants and microbiocides.  Silver has 
germicidal effects and kills many lower organisms effectively without harm 
to higher animals.  Silver has been known to be capable of rendering stored 
drinking water potable for a long period of time (several months).  Water 
tanks on ships and airplanes are often silvered.  Disposal of even small 
quantities of silver nitrate, AgNO3, connected to a septic tank is guaranteed 
to destroy the septic bacteria and require pumping out, flushing and seeding 
with fresh bacteria.  Silver nitrate antiseptic properties are known and a very 
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dilute solution is sometimes dropped into newborn babies’ eyes at birth to 
prevent contraction of gonorrhea or Chlamydia from the mother.  Silver 
chloride, AgCl is used to help prevent bacteria from growing on glass (when 
melted into the glass).  Silver carbonate, Ag2CO3 is used as an antibacterial 
agent for concrete.  It is also used as abiocide against bacteria, yeasts and 
molds in some paints and resins.  In today’s marketplace, Samsung has in-
troduced washing machines that inject silver ions into the wash and rinse 
cycles to kill 99.9% of odor causing bacteria.  Silver atoms, electrolytically 
stripped of an electron, are injected during the wash and rinse cycles, allow-
ing 100 quadrillion silver to penetrate deep into the fabric, sanitizing clothing 
without the need for hot water or bleach.  On the other hand, Kohler has in-
troduced a line of toilet seats that include an antimicrobial agent formed into 
the plastic which inhibits the growth of odor causing bacteria, mold and mil-
dew.  American Standard, StayCleanTM Whirlpool systems have plastic pipes 
manufactured with antimicrobial Alphasan® which are blue in color.  This 
revolutionary material uses silver’s natural antimicrobial characteristics to 
help the whirlpool free of 99.9% of microbes, mold and mildew.  Electrical 
ionization units impregnate water with silver and copper ions.  These sanitize 
pools, spas and fountains without the harsh effects of chlorine.  AgION® Sil-
ver-based antimicrobial protects Logitech wireless keyboard and mouse 
against a broad spectrum of bacteria.  In medicine, silver or silver com-
pounds are used externally in wound and burns treatment: Curad®’s natural 
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silver antimicrobial bandages, through laboratory testing showed that silver 
reduced bacterial growth like Staphyloccocus aureaus, E. coli, E. hirae and 
Pseudomonas aeruginosa (a powerful germ that does not respond to many 
antibacterials) in the dressing for 24 hours.  Elastoplasts®’s Silver HealingTM 
bandages contain silver ions which kill over 150 different bacteria, fungi, 
yeast and other harmful germs.  Silver sulfadiazine is an antibacterial and 
antifungal agent used as a topical cream to prevent and treat skin infections 
on areas of burned skin. Silver chloride has the ability to eliminate or flush 
out mercury from the body.  It is also used as an antimicrobial agent in 
some infection resistant surgical fabric materials.  Silver carbonate is used 
as a biocide against bacteria, yeast and molds in some cosmetics. It is also 
used in some tooth surface treatments to prevent cavities.  However, silver 
plays no known natural biological role in humans, and possible health effect 
of silver has been a subject of dispute.  Silver itself is not toxic but most sil-
ver salts are, and some may be carcinogenic.  Silver and compounds con-
taining silver (like colloidal silver) can be absorbed into the circulatory sys-
tem and become deposited in various body tissues, leading to a condition 
called argyria which results in a blue-grayish pigmentation of the skin, eyes, 
and mucous membranes.  Although this condition does not harm a person’s 
health, it is disfiguring and usually permanent (11AAM115). 
In the present work, silver perchlorate serves as a source of silver which 
forms complexes with various organic donors, to form solid complexes.  
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These complexes are then tested on wound healing by carrying out the anti-
bacterial assessments on bacteria that has been implicated in wounds.  Sil-
ver perchlorate is an effective reagent for replacing halides ligands with per-
chlorate, which is a weak or non-coordinating anion.  However, the use of 
silver perchlorate in chemical synthesis has declined due to safety concerns 
about explosiveness of perchlorate salts. 
Silver perchlorate is a chemical compound with the molecular formula 
AgClO4.  As earlier mentioned, it is a source of silver, responsible for anti-
bacterial properties in wound healing.  Dendrimer silver complexes and na-
nocomposites serve as antimicrobial agents, tested in vitro against Staphylo-
coccus aureus, Pseudomonas aeruginosa, and Escherichia coli bacteria 
(01NL218). They include silver complexes of poly(amidoamine) dendrimers.  
Their findings showed that both silver complexes and nanocomposites dis-
played considerable antimicrobial activity. 
α-Pinene is a unique ligand and in the coordination compounds is coordi-
nated basically in an η2-manner, e. g., 19 (02JA15099, 05OM1786) or di-
nuclear 20 (06RJG1288), as well as in silver perchlorate complexes, al-
though no structural information is given (71CJC2760).  Another way of 
coordination of α-pinene is σ-alkyl-π-allyl mode 21 followed by restructuring 
of the terpene to the so-called seco-pinene system including opening of the 
four-membered internal ring (91TL6101, 02OM2504). η3-Allyl coordination is 
noted in the palladium complexes of β-pinene (99ICA246). 
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E. MICROBIOLOGICAL ASPECT 
One of the properties of essential oils is in their possession of antimi-
crobial properties which include antibacterial, antiviral and antifungal proper-
ties.  The antibacterial properties of essential oils have been well recognized 
for many years (99JAM985).  They have been found applicable as naturally 
occurring antimicrobial agents in pharmacology, pharmaceutical botany, 
phytopathology, medical and clinical microbiology, and food preservation.  
Essential oils of aniseed, lavender, lemon, orange, lime, rosemary, and basil 
have been shown to possess antibacterial, antifungal, antiviral, insecticidal 
and antioxidant properties.  Some of them have been reportedly used in 
cancer and HIV treatments, while others have been used in food preserva-
tion, aromatherapy and fragrance industries (94FM334).  Some researchers 
have concluded that cinnamon, clove, and rosemary oils had antibacterial 
and antifungal activity (05MI1).  Anti-inflammatory activity has been found 
in basil, anti-diabetic property in cinnamon oil, and antioxidant property in 
53 
 
lemon and rosemary oils.  Orange was reported to have anticancer proper-
ties while lavender oil antibacterial and antifungal activity (02PR301). 
Plant essential oils exhibit antibacterial activity by interfering and destabi-
lizing the phospholipids bilayer of the cell membrane, enzyme systems, and 
genetic materials of bacteria (95JAF2839).  The antibacterial properties of 
these compounds are in part associated with their lipophilic character, lead-
ing to accumulation in membranes and energy depletion in a membrane-
associated event.  In addition, a number of constituents of essential oils 
(98JAB211) exhibit significant antibacterial properties when tested separate-
ly by interfering at different levels of mechanism.  It is evident that essential 
oils are more strongly antibacterial than is accounted for by the additive ef-
fect of their major antimicrobial components as a result of their minor com-
ponents that appear, to play a significant role synergistically (94RIE13).  
Some essential oil components such as carvacrol, thymol and eugenol (phe-
nolic compound) have been proven to be antibacterial.  Phenolic compounds 
are commonly found in both edible and non-edible plants, and they have 
been reported to have multiple biological effects, including antioxidant activi-
ty.  The importance of the antioxidant constituents of plant materials in the 
maintenance of health and protection from coronary heart and cancer is also 
raising interest among scientists, food manufacturers, and consumers as the 
trend of the future is moving toward functional food with specific health ef-
fects (91MI2).  The antioxidant activity of phenolics is mainly due to their 
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redox properties, which allow them to act as reducing agents, hydrogen do-
nors, and singlet oxygen quenchers.  In addition, they have a metal chela-
tion potential (95FRR375). 
Microbiological tests will be carried out on the terpenes and the drugs to 
see their effects on interaction.  It will be shown and reported if their inte-
raction is synergistic, indifferent or antagonistic. Not only is this aspect of 
the interaction of essential oil components with drugs of interest. Terpenes 
may also enhance penetration of certain drugs through the skin directly into 
the blood stream, thus bypassing gastrointestinal and hepatic elimination 
pathways (04ADD603). Terpenes may be hydrophobic permeants, while 
oxygenated terpenes may act by a hydrophilic pathway using ability of their 
oxygen-containing functional groups (epoxy, hydroxyl, keto, carboxyl, or es-
ter) to form hydrogen-bonded or charge-transfer complexes (04JCR113). 
Their formation could weaken intermolecular forces in the drugs, and they 
act at a submolecular, perhaps nanosized, level. The strength of the com-
plexes could influence on the penetration ability of a drug. Thus, for 5-
fluorouracil permeability in the presence of 1,8-cineole is about 90 times 
higher than the permeability in the presence of α-pinene in accord with their 
hydrogen bonding ability (08IJP40). 
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III. Experimental 
A. ESSENTIAL OIL EXTRACTION METHODS 
Extraction is needed in order for the oil, lodged in the hidden parts of the 
plant, to be released.  Every part of the plant contains oil, and the only way 
to release and utilize it, is through the process of extraction. The essential 
oils are obtained from various parts of the plants and from the seeds. Cin-
namon oil, for example, is obtained from the bark and the leaves. The yield 
and the quality of the oil largely depend on the handling and storage condi-
tions of aromatic plant materials. As soon as the plant material is harvested, 
certain changes start taking place and these include: loss of water content of 
the plant material, loss of volatile oil, changes in the physico-chemical val-
ues of the oil, and deterioration of the oil present in the plant material.  
Therefore, it is advisable to extract the essential oil from the plant material 
as soon as it is harvested. The essential oils are enclosed in oil glands or oil 
sacs, present in the cellular structures of the plant materials. The extraction 
of the essential oil depends entirely on the rate of diffusion of the oil through 
the plant tissues to an exposed surface from where the oil can be removed 
by a number of processes. 
The chemical composition of oil has been a subject of considerable stu-
dies (86PM96, 94PF33, 98JEO119).  Different studies showed that the chem-
ical composition depends on many parameters as the technique of extraction 
(04JC(A)323), geographical origin of the plant (02PR769) and the part of the 
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plant analyzed (96IJG1063, 02PR769). Although distillation is a very conve-
nient method for extracting essential oils, some disadvantages are caused by 
the artifacts produced during the process, especially when thermolabile 
components are involved (94MI2).  Supercritical fluid extraction is an inter-
esting technique to resolve the problem encountered by the hydrodistillation, 
and different studies have been reported in the literature (96IJG1063, 
97CES3421, 99JSF235). 
Another important aspect in the essential oil industry is the enhancement 
of the quality of the oil. As essential oils used in the food and perfume indus-
tries are commonly isolated by cold pressing, they contain more than 95% of 
monoterpene hydrocarbons, mainly limonene. The industrial practice of de-
terpeination of ‘folding’ is to remove some of the limonene along with other 
unsaturated terpenes and to concentrate the oxygenated fraction. This 
process is carried out in order to improve the oil stability, increase the solu-
bility of the oil in low proof alcohol, in food solvent and in water and to re-
duce storage and transport costs (99TAC708).  The commercial method cur-
rently used for folding essential oils is fractional vacuum distillation 
(83JFS1197), selective solvent extraction (86JFS1180), and chromatograph-
ic separation (98MI1).  All these methods have important drawbacks, such 
as low yields, formation of by-products (owing to the time of exposure to 
high temperatures) and the presence of toxic organic residues in the ex-
tracts (99TAC708).  Microwave-assisted extraction (MAE) is a popular and 
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developing method which has been proved to have many advantages such 
as rapidity, simple instrumentation, etc. (05JC(A)275, 06ABC810).  A novel 
method, solvent-free microwave extraction (SFME) has been developed in 
recent years (04JC(A)323).  For fresh plant materials, SFME can be used to 
extract essential oils directly.  However, for dried plant materials, it is neces-
sary to moisten the samples before extraction which makes the process, 
complex and time-consuming. Two types of extraction methods employed in 
this study are discussed below. 
1. Solvent- free microwave extraction 
With increasing energy prices and drive to reduce carbon dioxide emis-
sion, concerned institutions are being challenged to find new technologies in 
order to reduce energy consumption, to meet legal requirements on emis-
sions, and for cost reduction and increased quality.  For instance, existing 
extraction techniques have considerable technological and scientific bottle-
necks to overcome: often requiring more than 70% of total process energy 
used (08JC(A)229).  
Solvent-free microwave extraction was carried out with a Milestone Dry 
DIST (2008) microwave apparatus (Fig. 3).  The multimode microwave reac-
tor has a twin magnetron (2,800 W, 2,450 MHz) with a maximum delivered 
power of 1000 W in 10 W increments.  A rotating microwave diffuser ensures 
homogenous microwave distribution throughout the plasma-coated PTFE 
cavity (35cm x 35cm x 35cm).  The temperature is monitored by a shielded 
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thermocouple (ATC-300) inserted directly into the corresponding container.  
Temperature is been controlled by feedback to the microwave power regula-
tor.  In a typical SFME procedure, a 100 g of the leaves of Lavandula offici-
nalis were placed in the reactor.  The essential oil is collected after the ex-
traction process. 
 
Figure 3: Solvent-Free Microwave Extraction Setup 
2. Hydrodistillation 
Hydrodistillation is a traditional method of extraction. It is one of the old-
est and easiest methods being used for the extraction of essential oil.  In 
this method, the plant is fully dipped in the water.  The plant material is 
placed in water and heated directly in a Clevenger type distillation apparatus 
(Figure 4).  The essential oils whose boiling points normally range up to 
3000C are distilled with steam and both are condensed and separated. The 
distillation is usually done at atmospheric pressure, although vacuum 
processes are used if the oil is subject to hydrolysis (12MI1).  Since most 
59 
 
essential oils are prepared by this method, and have a specific gravity less 
than water some essential oils processed in this form may have a small 
amount of water at the base of the flask.  This is a form of disadvantage.  
Hence it is necessary to dry the oil over anhydrous sodium sulfate. However, 
the advantage of this method over isolation method such as solvent extrac-
tion is that the isolates obtained do not include non-volatile matter, which 
may interfere with chromatographic analysis.  It should also be noted that 
the yield of essential oil, using hydrodistillation process, is very small 
(96NFJ78). 
 
Figure 4:  Hydrodistillation Setup 
B. GC-MS ANALYSIS AND IDENTIFICATION OF COMPONENTS 
GC MS is standard equipment used to analyze essential oils (Fig. 5).  Gas 
chromatography-mass spectroscopy is a method that combines the features 
of gas-liquid chromatography and mass-spectrometry to identify different 
substances within a sample.  The GC-MS analyses was carried out using 
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Hewlett-Packard HP 5973 mass-spectrometer interfaced with an HP-6890 
gas chromatograph with an HP5 column.  The following conditions were 
used: initial temperature 70°C, maximum temperature 325°C, equilibration 
time 3 min, ramp 4°C/min, final temperature 240°C; inlet: split less, initial 
temperature 220°C, pressure 8.27 psi, purge flow 30 mL/min, purge time 
0.20 min, gas type helium; column: capillary, 30 m × 0.25 mm, film thick-
ness 0.25 µm, initial flow 0.7 mL/min, average velocity 32 cm/s; MS: EI me-
thod at 70 eV. 
 
Figure 5: GC-MS Setup 
Components of the oils were identified by matching their mass spectra 
and retention indices with those of the Wiley 275 library (Wiley, New York) 
in the computer library and literature (87MI1).  Yield of the oil was calcu-
lated per gram of the plant material, while the percentage composition was 
calculated from summation of the peak areas of the total oil composition. 
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4. UV/VIS SPECTROSCOPY 
Pure compounds used in the experiments are α-pinene, camphor and 1,8-
cineole [Sigma-Aldrich (For R&D use only), 1,8-cineole: 99%, α-pinene: 
98% camphor: 99%.  They were purchased as pure substances and used 
without further purification.  The pure compounds in this case are acting as 
the donors while iodine is an acceptor.  The UV-VIS analysis was carried out 
using the UV-3000 PC spectrometer.  
Methylene chloride (CH2Cl2), a solvent for spectrophotometric studies, 
was purified according to the following procedure (09MI1). Methylene chlo-
ride was washed with some portion of concentrated sulfuric acid, H2SO4 until 
the acid layer remains colorless. Afterwards, the solvent is washed with dis-
tilled water. The solution is then washed with 20% sodium carbonate solu-
tion (Na2CO3) and with distilled water and later dried over calcium chloride 
(CaCl2). The solution is filtered off and distilled over CaH2 before use. On dis-
tilling, the fraction boiling point 40-41°C was collected. Solution was then 
stored in a brown bottle, away from light over Type 3A molecular sieves. 
The iodine supplied is purified by procedure of re-sublimation.  Iodine 
crystals in a beaker are heated, causing it to sublime onto an evaporating 
dish cooled by ice. 
Two kinds of UV-VIS experiments were performed, one with the purpose 
to determine stability constants of the charge-transfer complexes, and 
another to characterize kinetics of their formation. 
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Charge transfer complexes formation between pure compounds and 
iodine were studied in the following manner. 1.0 × 10-3 M  stock solution of 
iodine was prepared. Series of solution of α-pinene, camphor and 1,8-cineole 
were prepared in CH2Cl2, 8.0 × 10-3 M, 7.0 × 10-3 M, 6.0 × 10-3 M, 5.0 ×      
10-3 M, 4.0 × 10-3 M, 3.0 × 10-3 M, 2.0 × 10-3 M, and 1.0 × 10-3 M. Solutions 
were freshly prepared just before recording spectra. Equal volumes of the 
iodine solution and each of the series of the pure compounds in methylene 
chloride were mixed in the cuvette. Pure solvent methylene chloride was 
used at the reference cuvette. The work cuvette is rinsed with methylene 
chloride before proceeding from solution to solution. Spectra are recorded in 
the range 300-600 nm. For measurements of kinetics of complex formation, 
one of the solutions of 1,8-cineole, for example, 6.0 x 10-3M, is taken (not 
discarded after the first recording of spectrum). Spectra are recorded after 
every 3 – 8 minutes until no changes in the spectrum is observed. Normally, 
10-12 measurements sufficed. Same procedures apply to other donors (α-
pinene and camphor).  
From the first series of measurements, the stability constant is deter-
mined for the equilibrium below was determined: 
D + A
Kf
[D-A]CT 
Benesi-Hildebrand analysis of Kf involves the measurement of the [D-A]CT 
absorbance (Abs) as a function of varied [A] when [A]>>[D].  A plot of y = 
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[D]0/Abs vs.  x = 1/[A]0 gives an intercept = 1/ε and slope = (1/Kfε) as de-
fined by the Benesi-Hildebrand equation: 
[]

=
1
[
]
1

+
1

 
Here [D]0 = total donor concentration (fixed); abs = CT absorption of the DA 
complex at a wavelength λ; [A]0 = total concentrations of an acceptor (va-
ried); Kf = equilibrium constant for DA complex formation; ε = molar ab-
sorptivity of DA complex at λ. The linear dependences were treated using 
the least squares’ method realized as the Microsoft Excel spreadsheet 
(04MI1). 
D. IR SPECTROSCOPY 
 Purification of the solvent CCl4: One liter (1 L) of CCl4 was treated with 
potassium hydroxide, KOH, and the mixture, shaken vigorously for 30min at 
50-60oC.  After washing with water, the process is repeated with half the 
quantity of KOH.  Ethanol is then removed by shaking, several times with 
500 mL of water, followed by shaking with small portion of concentrated 
H2SO4 until no further coloration was observed.  The CCl4 is then washed 
with water, dried over anhydrous CaCl2 and distilled.  Further purification 
was effected by passing the distilled solvent through a column of alumina 
and then allowing to stand in the presence of a type 5A molecular sieve and 
finally distilled before use.  Pure solvent of CCl4 was collected at the boiling 
point of 76.5oC. 
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 One of the approximate methods for the determination of the electron 
donor ability of the ligands is the IR-spectroscopic method. Using one of the 
standard donors (phenol, methanol, chloroform, phenylacetylene, and oth-
ers), it is possible to determine the frequency shift under hydrogen bonding, 
for example, for phenol, 
 ∆ν(OH) = νfree(OH) - νbound(OH) 
Comparison of the obtained value for a compound under investigation with 
the literature data allows to place a ligand in a series of the other electron 
donor molecules. Using various empirical dependences, it is possible to cal-
culate all the thermodynamic parameters of the hydrogen bond formed (∆H°, 
∆S°, and ∆G°), or, in other words, all the parameters for the equilibrium 
XH + L  XH ⋅⋅⋅ L 
 Approximately 20 mL of the stock 0.01 M phenol solution in CCl4 was pre-
pared. 3 mL of this solution were diluted with 3 mL of CCl4 up to the concen-
tration of 0.005 M. IR spectrum of this solution was recorded in the range 
2600-3700 cm-1 at a thickness of the absorbing layer of 4-5 mm, and ν(OH) 
of the non-associated phenol molecules were recorded. 3 mL of 0.04 M solu-
tions of the ligands under study in CCl4 (α-pinene, 1,8-cineole, camphor) 
were prepared and mixed with 3 mL of the stock phenol solution, so that the 
solutions containing phenol and a ligand in the ratio 1:4 (concentration 
0.005 and 0.02 M) are obtained. Spectra of these solutions are recorded in 
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the same range of frequencies. The values of  ∆ν(OH) of the associated phe-
nol molecules are calculated. 
 According to Badger-Bauer empirical equation (10MI1), the enthalpy of 
the hydrogen bond formation is 
∆H° = -67∆ν(OH)-2638 (J/mol) 
Empirical equation for the entropy change is valid for a wide range of mole-
cular complexes (07RCR1935): 
∆S° = 0.0297∆H° + 33.5 (J/mol K) 
The free energy of complex-formation is 
∆G° = ∆H° - T∆S° (J/mol) 
The equilibrium constant is 
 = ∆°/ 
Here R = 8.314 J/mol K. 
 Intensity of ν(OH) of the non-associated phenol molecules allows to cal-
culate the equilibrium concentration of the free phenol under the following 
equilibrium (L is an organic base): 
C6H5OH + L  C6H5OH⋅⋅⋅L 
The association constant is 
K =
[CHOH ∙ L]
[CHOH][L]
 
If c°p and c°L are the initial concentrations of phenol and ligand, and the 
equilibrium concentration of phenol is cp,  
66 
 
K =
c°" − c"
c"(c°% − c°" + c")
 
To find phenol concentration accurately, the calibration graph D = f(c) 
should be plotted using the data on phenol solutions of different concentra-
tion. 
 30 mL of a stock phenol solution in CCl4 was prepared with concentration 
at 0.01 M. By dilution, five working solutions of concentrations 0.001, 0.002, 
0.004, and 0.06 M were prepared, 20 mL each. IR spectra of these solutions 
were recorded in the range of ν(OH). For ν(OH) of the free hydroxyl group 
(3610 cm-1) the graph D = f(c) was plotted, which is a straight line passing 
through the coordinate origin. 
 By mixing 2 mL of 0.01 M solution of phenol in CCl4 and 3 mL 0.01 M or 
0.02 M of organic base, a working solution of the complex was obtained, in 
which c°p and c°L are twice less. IR-spectra of solutions were recorded in the 
range 2600-3700 cm-1. From the optical density of ν(OH) of the free phenol 
molecules at 3610 cm-1, the equilibrium concentration Cp was determined 
using the calibration graph. Stability constants were calculated using the 
formula above. 
E. MICROBIOLOGICAL TESTS 
1. Bacterial strains used in this study 
Four reference strains of bacteria used in this study were chosen based 
on their pathological effects on human and deterioration of food products. 
Gram positive bacteria Bacillus cereus, Staphlococcus feacalis,  and Gram 
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negative bacteria Proteus vulgaris and Pseudomonas aeruginosa were ob-
tained from the Department of Microbiology, University of Fort Hare.  
2. Culture media and growth condition 
The bacterial stock cultures were maintained on nutrient agar (SAAR-
CHEM, Gauteng, SA) plates. A loopful of bacterial cells from the nutrient 
agar plates was inoculated into 50 mL of a nutrient broth (DIFCO, California, 
USA) in a 250-mL sidearm Erlenmeyer flask and incubated at 37°C for 16 h 
with vigorous shaking (Orbital incubator, S150, UK). After incubation, the 
culture was diluted with fresh media to give an D600nm of 0.1. One hundred 
microliters of the culture cells was added onto the plate and spread into a 
bacterial lawn using a sterile glass spreader. 
3. Antimicrobial susceptibility test 
The agar well diffusion-based method (87IJF165) modified later 
(09AJB1280) was used to determine the susceptibility of bacteria.  A 100-µL 
volume of 18 h bacterial cultures were used to spread a bacterial lawn on 
nutrient agar. The cultures were adjusted to approximately 105 cfu/mL using 
McFarland standard. Twenty five microliters (25 µL) of various concentra-
tions of plant extracts was added to each well (diameter of 4 mm) of nu-
trient agar plate under aseptic condition. The plates were left for 30 min at 
room temperature for the diffusion of the extracts and incubated at 37°C for 
18 h. The zones of inhibition were measured after 18 h using ruler. Each 
concentration of the extract was repeated three times. 
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4. Determination of minimum inhibitory concentration (MIC) 
The minimum inhibitory concentration of the essential component and 
drugs was determined by the agar dilution method as described by the Na-
tional Committee for Clinical Laboratory Standards (1994). Dilution of the 
plant extracts ranging from 0.195-100 mg/mL in a Mueller Hinton agar solu-
tion were prepared by incorporating the extract stock solution into molten 
agar at 50°C. After pouring into plates and allowing the agar to set, the 
plates were inoculated with standardized Inocula of the test bacteria of 105 
CFU/mL. The plates were further incubated at 37°C for 24 h under aseptic 
conditions. The MIC’s were the lowest concentrations of the extract resulting 
in complete inhibition of visible growth of the test organisms. 
5. Time killed assay of combined drugs and essential oil compounds 
The effect of combinations of essential oil components with selected 
drugs was evaluated using the time-kill assay method in accordance with the 
descriptions (05AJB946). Inocula were prepared following the described 
guidelines of EUCAST (03CMI1). The essential oil components (α-pinene, 
camphor, and 1,8-cineole) were incorporated into 50 mL of nutrient broth at 
0.0625 × MIC. Both the test and control were inoculated with each organism 
to a final inoculum density of 105 CFU/mL. One hundred microliter, 100 µL of 
cultured bacteria were taken from the flask and serially diuted in steriled 
nutrient broth and plated on the nutrient agar in order to determine the zero 
hour counts and later incubated overnight at 37°C. The flasks containing the 
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organisms were further incubated for 8 hrs with shaking at 120 rpm at 37°C. 
After 8 hrs of incubation, the samples were taken from the control and each 
test flask and transfered to the recovery medium (nutrient broth) containing 
3% Tween 80 to neutralize the effects of the carry-overs drug and essential 
component from the test suspensions. The samples were serially diluted in 
sterile nutrient broth and one hundred microliter (100 µL)  plated on nutrient 
agar plate in duplicate and later incubated at 37°C for 24 hrs under aerobic 
conditions.  The number of colonies were counted after incubation and the 
mean of CFU/mL for each test and controls were determined and expressed 
as log10. The interactions of various essential oil components and drugs used 
in this study were considered synergistic, if there was a decrease of ≥ 2log10 
CFU/mL in colony counts, after 8 hrs. Additivity or indifferences was 
described as <2log10 CFU/mL in the average viable counts after 8 h for the 
combination, in comparison to the most active drugs. Antagonism was 
defined as ≥ 2log10 CFU/mL increase in colony counts.  
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IV. Results and Discussion 
A. ESSENTIAL OILS FROM LAVANDULA OFFICINALIS 
After completion of the extraction processes for both hydrodistillation 
(HD) and solvent-free microwave extraction (SFME), using the formula for 
yield, the following values were obtained for two different methods em-
ployed: 0.9% and 0.7% for HD and SFME, respectively. These amounts of 
percent yields, when compared with literature, show an improvement in 
terms of quantity with respect to the initial amount of plant materials, distill-
ed and microwaved, respectively. For instance, for a 500g of fresh plant ma-
terials distilled and microwaved the yields obtained were 0.35% and 0.33% 
respectively for Rosmarinus officinalis (09FC355). The higher yield in con-
ventional hydrodistillation method over SFME calls for a critical examination 
of what might have happened. This could be attributed to two different rea-
sons: firstly, to the loss of some volatile compounds during processing time, 
and secondly, to the manner in which the oils were collected in SFME. Collec-
tion of the oils in HD was made once but in the SFME oils were collected at 
intervals of hours, lasting into the following day. As the SFME set-up cools 
down, new oils were seen floating on top of the hydrosol and collected.  In-
accuracy and loss of oil arise during the process of collecting and transfer-
ring into the bottle.  However, after a visual inspection of the two oils, the oil 
for the SFME was found to be pure to the sight than those of the HD.  This 
purity is attributed to the shorter time of extraction as compared to the HD.  
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The longer time and heat experienced in HD allows higher molecular com-
pounds to be extracted, thereby impairing the purity of the oil.        
One of the merits of the solvent-free extraction method (SFME) over the 
conventional hydrodistillation (HD) is rapidity. The yields obtained by the 
two methods are of the same order of magnitude, the only difference is the 
time taken for the extraction processes. The chemical components of essen-
tial oils obtained from Lavandula officinalis by SFME and HD are shown in 
Table 3. A total of 59 compounds were identified in L. officinalis essential oils 
using the two techniques.  The methods allowed the detection of most vola-
tile active compounds such as α-pinene, camphor, verbenone, and cam-
phene. Slightly higher amounts of oxygenated compounds are present in the 
aromatic plant isolated by SFME, compared to HD.  Monoterpene hydrocar-
bons are found to be present in equivalent amounts in the SFME and HD es-
sential oils.  Some essential oils are also found to be absent in either of the 
methods as seen in Table 3. α-Phellandrene, δ-3-carene and α-terpinene 
were absent in SFME but present, in a minute amount in HD. In the same 
way, trans-β-ocimene was present in the essential oil extracted by SFME 
but, absent in HD. The oil obtained by SFME is slightly concentrated in oxy-
genated compounds than as obtained in HD. β-Pinene was found to be the 
major and the dominant monoterpene in the essential oil extracted from La-
vandula officinalis with the value 21.93% and 20.58% for HD and SFME re-
spectively, followed by α-pinene, 8.50% and 6.74%. 
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 1,8-Cineole was found to be the main oxygenated components in the es-
sential oil isolated from leaves with a difference of 2.13% between the two 
extraction methods. 1,8-Cineole for SFME has 44.84% but 46.89% for HD. 
The next in value is α-terpineol with 5.23% for SFME and 3.90% in HD. 
trans-Sabinene hydrate, D-fenchyl alcohol, α-thujone, fenchone, α-
campholene aldehyde, linalyl propionate, cumin aldehyde, and carvone were 
the oxygenated monoterpenes absent, using SFME method. They were found 
to be present in fairly low amount using HD.  Some oxygenated monoter-
penes are equally absent in HD but present in SFME.  These include filifo-
lone, trans-2-caren-4-ol, chrysanthenone, trans-pinocarveol, nopol, and my-
ternyl acetate.  Oxygenated monoterpene compounds are more valuable 
than the monoterpene hydrocarbons due to their contribution to the fra-
grance of the essential oil. Hence, the oxygenated compounds are highly 
odoriferous and most valuable. The greater proportion of the compounds de-
tected and the proportion of the oxygenated compounds in SFME essential 
oils could be attributed to the less thermal and hydrolytic effects, as com-
pared to HD which uses a large quantity of water. Essential oils contain or-
ganic compounds that strongly absorb microwave energy. Compounds with 
high and low dipole moments could be extracted in various proportions by 
microwave extraction. Organic compounds, like oxygenated compounds, 
having high dipole moment interact more vigorously with microwaves and 
can be extracted more easily in contrast with aromatic compounds having 
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low dipole moments (like monoterpene hydrocarbons).  Percentages of the 
identified sesquiterpenes and sesquiterpenoid components were relatively 
low, being 1.73% and 2.31% for HD and SFME respectively.  The main com-
ponents of this fraction in the examined leaves of L. officinalis are α-guaiene 
and α-bisabolene.  α-Guaiene is present only in the essential oil of SFME 
with a very low percentage of 0.26%. α-Bisabolene is also present in the 
amount of 0.26% in SFME and 0.25% in the HD essential oil. Occurrence of 
a very low content, as low as <2.5% for sesquiterpenes and sesquiterpeno-
ids using microwave-assisted process and HD in R. officinalis has been re-
ported (09FC355). 
Table 3: Chemical Composition of Lavandula officinalis Essential Oils Ob-
tained by SFME and HD 
No. Compounds   HD(%) SFME(%) RIa RIb  
Monoterpenes  33.8  30.7 
1.  α-Pinene    8.50  6.74  1037  1040 
2.  Camphene    0.52  1.26  1062  1245 
3.  β-Pinene    21.9  20.6  1111  1091 
4.  Myrcene     1.58  1.30  1108  1106 
5.  α-Phellandrene  0.07  —   1129  — 
6.  δ-3-Carene    0.07  —   1129  — 
7.  α-Terpinene   0.29  —   1151  — 
8.  γ-Terpinene   0.47  0.13  1197  1194 
9.  α-Terpinolene   0.24  0.65  1249  1248 
10. trans-β-Ocimene  —   0.16  —   1443 
11. Naphthalene   0.08  0.09  1796  1682 
  Oxygenated  
monoterpenes  66.4  68.5 
12. 1, 8-Cineole   46.9  44.8  1178  1165 
13. cis-Sabinene  
hydrate     0.12  0.20  1207  1205 
 
74 
 
14. trans-Sabinene 
 hydrate     0.12  —   1207  — 
15. Linalool     0.24  0.65  1249  1248 
16. D-Fenchyl alcohol 0.04  —   1269  — 
17. Filifolone    —   0.26  —   1254 
18. α-Thujone    0.72  —   1240  — 
19. Fenchone    0.72  —   1240  — 
20  α-Campholene  
aldehyde    0.20  —   1285  — 
21. Camphor    1.01  4.99  1311  1311 
22. Terpinen-4-ol   1.09  0.62  1357  1354 
23. α-Terpineol    3.90  5.23  1379  1374 
24  Linalyl propionate 3.90  2.35  1331  1327 
25. Myrtenol    2.15  1.44  1385  1381 
26. Verbenone    0.26  2.01  1400  1400 
27. trans-Carveol   0.10  0.10  1411  1411 
28. Cuminaldehyde  0.03  —   1440  — 
29. trans-2-Caren-4-ol —   0.10  —   1411 
30. Chrysanthenone  —   0.60  —   1283 
31. trans-Pinocarveol  —   1.08  —   1303 
32. Carvone     0.06  —   1445  — 
33. Bornyl acetate   0.14  3.70  1428  1429 
34. Nopol     —   0.30  —   1348 
35. Myrtenyl acetate  —   0.07  —   1469 
  Sesquiterpenes  1.58  2.01 
36. trans-α- 
Bergamotene   0.07  0.22  1581  1579 
37. β-Sesqui- 
phellandrene   0.03  0.05  1598  1642 
38. epi-Bicyclosesqui- 
phellandrene   0.19  0.05  1598  1621 
39. (Z,E)-α-Farnesene —   0.22  —   1579 
40. β-Cubebene   0.25  0.15  1612  1632 
41. β-Selinene    0.25  —   1646  — 
42. β-Bisabolene   0.07  —   1667  — 
43. Germacrene-D  0.05  0.15  1674  1632 
44. α-Guaiene    —   0.26  —   1646 
45. cis-Calaminene  0.08  0.09  1683  1682 
46. α-Bisabolene   0.25  0.26  1701  1701 
47. α-Humulene   0.25  —   1701  — 
48. β-Caryophyllene  —   0.17  —   1574 
49. trans-β-Farnesene 0.04  0.09  1643  1620 
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Oxygenated 
 sesquiterpenes 0.15  0.30 
50. Caryophyllene  
oxide      0.05  0.08  1744  1744 
51. α-Bisabolol    0.07  —   1840  — 
52. β-Eudesmol   0.03  0.12  1813  1810 
53. Nerolidol    —   0.10  —   1655 
  Other  
oxygenated  
compounds   5.31  4.43 
54. Heptan-2-ol   0.04  — 
55. Heptan-3-one   0.05  0.38 
56. 3-Cyclohexene- 
1-methanol    3.11  2.35 
57. 3-Cyclohexene-1-ol —   0.62 
58. Heptan-3-ol   2.11  1.08 
Extraction time (min)  180  45 
Yield (%)      0.9  0.7 
Total oxygenated  
compounds (%)    66.2  69.3 
Total non-oxygenated  
compounds (%)    33.8  30.7 
RIa and RIb – Retention index for HD & SFME, respectively.  
 
 In conclusion, SFME and HD of essential oils in Lavandula officinalis have 
been reviewed and studied with a lot of additional inputs to knowledge.  Mi-
crowave extraction makes use of the physical and chemical phenomena that 
are differently compared with those applied in conventional isolation tech-
niques. Microwave extraction method produces essential oil in a concen-
trated form, free from any residual solvents or contaminants. This piece of 
work has further added to knowledge and to the proof that solvent-free mi-
crowave extraction has an outstanding edge over conventional methods in 
providing shorter extraction time (45 min against 3 h), low cost (energy cost 
is greatly reduced in SFME), and cleaner features.  The main component 
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found in the Lavandula essential oil was 1,8-Cineole, an oxygenated mono-
terpene that has found its usefulness as possessing antispasmodic and anti-
fungal properties. This component, 1,8-cineole, along with camphor and α-
pinene are the three major pure compounds the project work centers on. 
B. MOLECULAR IODINE CHARGE TRANSFER COMPLEXES 
According to the procedure, the electronic absorption spectra of iodine 
(1.0 × 10-3 M) in the presence of increasing amounts of the various donors 
(α-pinene, 1,8-cineole, and camphor) in methylene chloride, CH2Cl2 at 25°C 
are shown in Figures 6-8.  The spectra obtained for the donor-I2 systems 
show new maximum absorption bands at wavelengths which are not due to 
the absorption of any of the reactants, and it was considered to be as a re-
sult of charge-transfer complex formation. 
 
Figure 6: Absorption Spectra of α-Pinene-I2 CT Complex at 25oC in CH2Cl2 
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Figure 7: Absorption Spectra of 1,8-Cineole-I2 CT Complex at 25oC in CH2Cl2 
 
Figure 8: Absorption Spectra of Camphor-I2 CT Complex at 25oC in CH2Cl2 
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 For the α-pinene-I2 reaction (Fig. 6), while none of the reactants show 
any considerable absorption in the range 330-390 nm, the spectra obtained 
immediately after mixing iodine with the alpha-pinene resulted in the ab-
sorption around 330-390 nm,  presumably due to the complex formation of 
iodine with α-pinene.  Spectra of this system (α-Pinene-I2) are characterized 
by the appearance of a new band at 360 nm beside the presence of the blue 
shifted iodine band at 500 nm (Fig. 6).  The intensity of the new band in-
creases, as the concentration of the donor (α-Pinene) is increased.  It is evi-
dent that the broad band located around 500 nm that is due to the electronic 
transition of free iodine (69MI2) exhibit a hypsochromic shift due to com-
plexation with the added α-pinene.  Thus, the new band located at 360 nm is 
assigned as a charge-transfer band.  The new, low energy absorption ob-
served in solution containing both a donor and an acceptor has been de-
scribed by Mulliken (69MI2) as charge transfer transition involving the exci-
tation of an electron on the donor to an empty orbital on the acceptor.  The 
absorbance of the CT complex was then measured at its maximum absorp-
tion wavelength.  Also, it should be noted that the band around 364 nm is 
well known to be characteristic for the formation of triiodide ion, I-3, in the 
process of complex formation between iodine and different electron pair do-
nating ligands (81JPC1789, 91SA743).  This was further supported by con-
ductivity measurements of an 8 X 10-3 M solution of α-pinene in methylene 
chloride before and after addition of iodine.  Just after the addition of the 
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iodine to the α-pinene solution (with negligible conductivity), the conductivi-
ty of the solution is 0.1 µS; after 300 seconds, the conductivity increases to 
0.39 µS, indicating the gradual release of I-3 ion from its molecular complex 
with α-pinene into the solution.  A similar observation is noted for the 1,8-
cineole-I2 and camphor-I2 systems. 
 In a similar manner, the reaction of 1,8-Cineole with iodine resulted in a 
spectra, showing a completely new absorption band, different from the initial 
absorptions of the reactants. Two different bands of 300 nm and 340 nm 
were observed, extending to around 370 nm (Fig. 7).  The absorption spec-
tra of camphor-I2 complex also gave rise to two different absorption bands 
at 300 nm and 340 nm, extending to around 370nm.  These bands belong to 
neither of the reactants (Fig. 9).  Similarly, within the same time frame, the 
conductivity of the 1,8-Cineole increases from 0.01 µS to 0.36 µS while that 
of camphor rose from 0.10 µS to 0.52 µS respectively. 
 The original Benesi-Hildebrand equation was modified into the following 
form: 
['(]

=
1
[)]
1
*
+
1
*
 
Here [I2]0 and [L]0 are the total concentration of the acceptor and donor, re-
spectively; abs is the absorbance of the complex at λmax; εCT is the molar ab-
sorptivity of the complex; Kf  is the association constant of the complex (L 
mol-1). Modified Benesi-Hildebrand equation above is used to calculate the 
association constants Kf and molar absorptivity co-efficient εCT, as has been 
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done by other workers (05SA(A)2017, 08JCSP209, 08JIC610, 
09AX(E)m1191, 11ARJC105).  Values of Kf and εCT are calculated from the 
equation by varying the concentration of donor [L]0 and keeping the concen-
tration of acceptor [I]0 constant such that [L]0>>[I]0.  Equation is of the 
form: Y = MX + C and the plot of [I2]0 Vs 1[L]0 is fairly linear and the sam-
ple linear plots are as shown in Fig. 9-11.  From the intercepts and slopes, 
the values of εCT and Kf can be evaluated.  Such a fair linear relationship in 
the resulting Benesi-Hildebrand plots is a good evidence for the 1:1 stoichi-
ometry of the charge transfer complexes studied.  The ∆G° values of the 
complex were also calculated from the Gibbs free energy of formation ac-
cording to the equation below.  
∆G° = -2.303 RT log KCT 
Here ∆G° is the free energy change of the complexes (KJ mol-1), R is the 
gas constant (8.314 J mol-1 K), T is the temperature in Kelvin (273 + °C) 
and, KCT is the association constant of the complexes, which is Kf in this case 
i. e. KCT = Kf. The calculated εCT, Kf and ∆G° values are also included in the 
Table 4.  
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Figure 9: Benesi-Hildebrand Plot for α-Pinene-I2 at λ = 360 nm 
 
Figure 10: Benesi-Hildebrand Plot for 1,8-Cineole-I2 at λ = 340 nm 
 
Figure 11: Benesi-Hildebrand Plot for Camphor-I2 at λ = 320 nm 
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Table 4: Data for Benesi-Hildebrand Study of Various Complexes in CH2Cl2 at 
25°C 
Complex  λmax (nm) εCT (M-1cm-1)  Kf  r2  -∆G° (KJ mol-1) 
1 α-Pinene-I2  360  55      220 0.999 13.37 
2 1,8-Cineole-I2 340  55      759 0.993 16.43 
3 Camphor-I2  320  45      966 0.971 17.03 
 A critical look at the Table 4 reveals the values of both Kf and εCT asso-
ciated with the complexes in solution under study.  The values of Kf and εCT 
obtained is smaller, compared to what has been previously recorded 
(05SA(A)205, 08JIC610), although, relatively lower values of Kf have also 
been reported (98MC121).  Generally, relatively low Kf values suggest that 
the formed complexes are of the weak type, i. e., the ground state wave 
function has predominantly a nonbonding structure.  Lower values of Kf and 
εCT obtained in this case indicate low stabilities of the formed charge-transfer 
complexes as a result of the expected low donation of a donor nucleus.  
Complexes are expected to form instantaneously, depending on the envi-
ronmental condition; they break apart, back into solution.  In fact, the reac-
tion is better explained as being in equilibrium with the complex formed in 
solution.  The results listed in Table 4 clearly reveal that stabilities of the 
complexes of donors with the same σ-acceptor (I2) are of the order 3 > 2 > 
1. This behavior could be ascribed to the higher ability of the n-donors  
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compared to that for the π-donor α-pinene. High values of εCT however agree 
with the existence of triiodide species (72CPL151, 80IC463).   
 The values of the Gibbs free energy of formation, ∆G° obtained indicate 
that complexation is thermodynamically favored.  The free energy change of 
the complexation also reveals that the charge transfer complex formation 
between used donors and acceptor is exothermic in nature. The values of 
∆G° are generally more negative as the association constants of the molecu-
lar complex increase. As the bond between the components becomes 
stronger and thus the components are subjected to more physical strain or 
loss of freedom, the values of ∆G° become more negative. 
 In a similar manner, according to the procedure, kinetics of complex-
formation in a solution was studied. The concentration of 6 × 10-3 M of vari-
ous complexes was used, as a way of monitoring the change in absorption 
with time.  The following graphs were obtained for the kinetics measurement 
(Figures 12-14). They are preceded by possible structures of the charge-
transfer complexes formed. 
I I-3
O
O
I I-3
I I-3
 
84 
 
 
Figure 12: Absorbance-Time Plot at 25°C for a 6 x 10-3 M α-Pinene-I2 Com-
plex in CH2Cl2 
 
Figure 13: Absorbance-Time Plot at 25°C for a 6 x 10-3 M 1,8-Cineole-I2 
Complex in CH2Cl2 
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Figure 14: Absorbance-Time Plot at 25°C for a 6 x 10-3 M Camphor-I2 Com-
plex in CH2Cl2 
 A gradual increase in absorbance with time occurs in all cases in accord 
with similar results (08JIC610). 
C. ANTIMICROBIAL TESTING OF ESSENTIAL OIL COMPONENTS AND THEIR MIXTURES WITH 
DRUGS 
The result of the antimicrobial activity of the pure compounds from the 
essential oil components and the various drugs was presented in Table 5.  At 
a glance, it can be observed that the pure compounds, camphor and α-
pinene showed a very low activity and as such, all bacteria tested were re-
sistant to their individual treatment with MIC ≥ 100 mg/mL.  This observa-
tion was contrary to the report (92FFJ121), which demonstrated the potent 
antimicrobial activity of α-pinene and camphor against some bacteria.  In a 
similar manner, 1,8-cineole was equally observed to have the same MIC val-
ues as the other two pure compounds on two different strains of bacteria – 
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P. aeruginosa and B. cereus.  These results, showing the resistance of B. ce-
reus and P. aeruginosa against the treatment of 1,8-cineole concurred with 
the report (93PMP331) on certain strains of bacteria, while P. vulgaris and S. 
feacalis were susceptible at the MIC values of 25 and 50 mg/mL, respective-
ly.  Among all the remaining drugs under study, resorcinol is the only one 
showing the least activity on all the bacteria strains with the MICs, equal in 
value to camphor and α-pinene.  Following suit is the drug Eskamel with the 
MIC values of 100 mg/mL on two strains of bacteria tested, S. feacalis and 
P. aeruginosa. Eskamel, however showed a better MIC value of 0.3906 
mg/mL on P. vulgaris, followed by MIC value of 25 mg/mL on B. cereus.  
Among all the drugs examined, silver perchlorate showed the greatest activi-
ty on all the bacteria strain.  The highest potency was observed on the bac-
teria P. vulgaris with the MIC value of 0.781 mg/mL.  MIC values of 1.563 
mg/mL was obtained for two different strains – S. feacalis and P. aeruginosa 
while the least activity recorded for the drug was 3.125 mg/mL with respect 
to B. cereus.  It would be interesting to know that the Gram negative bacte-
ria tested in this study were susceptible to the treatment of silver perchlo-
rate, despite their cell wall compositions.  The data showed that silver per-
chlorate has a potential antibacterial activity, though the mechanism of ac-
tion was not investigated in this study. Silver perchlorate is a very good 
source of silver ions in solution, which have been proven to have antibacteri-
al properties (70AS281, 01NL218).  The results obtained for the drug, Beta-
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dine were alarming, and contrary to what has been reported (64JH509, 
94JMM408, 10JAS70).  The MIC values of >10 mg/mL was obtained for all 
the bacterial strains. On a repeat course, the same values were recorded.     
On combination, the treatment of the various pure compounds with the 
drugs gave results, some of which are better than when tested on the bac-
terial strains, alone using the time-kill study (Table 6).  The data obtained 
are presented in terms of the log CFU/mL change and are judged relative to 
the conventional definition of bacterial activity which is 3-log CFU/mL or 
greater reduction of the initial inoculums within 8 hrs (03AA1). The antibac-
terial activity of 1,8-cineole has been reported to have no antibacterial activ-
ity against selected bacteria, while camphor and α-pinene have been shown 
to possess potent inhibitory effect against the growth of some bacteria 
(93PMP331, 08RA1343). The results obtained from this present study 
showed a potent synergic biocidal effect of camphor plus silver perchlorate 
combination (0.0625 ×MIC each) against all tested bacteria.  This combina-
tion resulted to log reduction of the bacteria between 4.25 and 3.64 as 
shown in Table 6.  The individual combination of camphor with Eskamel and 
resorcinol showed additive effect against P. aeruginosa but synergic biostatic 
effect against P. vulgaris and synergic biocidal against S. feacalis and B. ce-
reus.  The log reduction of all the tested bacteria showed indifference or ad-
ditive effect against the combination of α-pinene and resorcinol except P. 
vulgaris with synergic bacteriostatic effect. The log reduction of all the tested 
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bacteria showed indifference or additive effect against the combination of α-
pinene and resorcinol except P. vulgaris with synergic bacteriostatic effect.  
Time kill of α-pinene combined with silver perchlorate against the bacteria 
tested was synergic against S. feacalis with an additive effect. Similarly, 
both P. vulgaris and P. aeruginosa show additivity to the combination of α-
pinene and Eskamel but, showed biostatic synergy effect against other bac-
teria.  Generally, most combinations of essential oil compounds and the 
drugs, used in this study were synergistic or additive against both Gram 
negative and Gram positive pathogenic bacteria, depending on the tested 
species and the interaction of combined agents as shown in Table 6. The an-
tibacterial activity of 0.0625 × MIC of these compounds resulted to many 
fold reduction of bacterial growth compared with MIC values of the agents, 
alone. Our present study reported the antibacterial properties of Eskamel, 
resorcinol and silver perchlorate for the very first time. Among the drugs 
tested, silver perchlorate showed the strongest antibacterial activity against 
all tested bacteria with synergistic effect. The interaction of 1,8-cineole with 
the three tested drugs enhanced its antibacterial activity, synergistically 
against the bacteria used in this study. The synergy detected in this study 
was not specific to any group of bacteria but, could be related to the synerg-
ism of functional groups. The strong synergy observed between these com-
pounds and drugs is a significant finding, demonstrating the therapeutic po-
tentials of the essential oil components with lower antimicrobial properties 
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(11IJM4477).  However, the synergy pattern of these compounds observed 
in this present study is suspected to depend on the interactive modes of ac-
tion rather than concentrations of the two agents in combinations.  The data 
obtained from this study indicate the major role played by the concentra-
tions, relative to MIC.  Meanwhile, further studies on the mechanisms of 
these compounds needed to justify the outcome of this experiment. 
Table 5: Minimum Inhibitory Concentrations, MICs (mg/mL) of Reagents 
Used 
      P. vulgaris S. faecalis P. aeruginosa  B.cereus  
1. Resorcinol   100    100   100    100 
2. Eskamel    0.3906   100   100    25 
3. AgClO4    0.7813   1.5625  1.5625   3.125 
4. Betadine    >10    >10   >10    >10 
5. Camphor   100    100   100    100 
6. 1,8-Cineole   25     50    100    100 
7. α-Pinene    100    100   >100    100 
 
Table 6: Time-Kill Study for Combination of Essential Oil Compounds 
and Drugs 
Reagent Combinations  P. vulgaris S. faecalis P. aeruginosa B. cereus 
Camphor + AgClO4    3.65   4.01   3.90    4.52 
Camphor + Eskamel    2.47   3.23   1.94    3.12 
Camphor + C6H4(OH)2   2.95   11.09  1.89    2.46 
Camphor + Betadine   ND   ND   ND    ND 
α-Pinene + AgClO4    2.70   1.07   10.91   3.42 
α-Pinene + Eskamel    1.67   2.63   1.32    2.00 
α-Pinene + C6H4(OH)2   2.75   1.26   1.38    1.71 
α-Pinene + Betadine   ND   ND   ND    ND 
1,8-Cineole + AgClO4   3.65   2.83   2.91    10.72 
1,8-Cineole + Eskamel   2.05   4.01   2.03    2.12 
1,8-Cineole + C6H4(OH)2  1.31   2.48   1.53    2.06 
1,8-Cineole + Betadine   ND   ND   ND    ND 
Log reduction index were interpreted as follows: <2.0 – additive; ≥2.0 - syn-
ergic. 
AgClO4 represents silver perchlorate; C6H4(OH)2 represents resorcinol. 
ND – Not Determined. 
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Figure 15: Some of the Colonies of Growth Observed, on Examination after 
24 h of Incubation 
Some of the colonies, on observation were photographed to depict the 
growth patterns of the microorganisms in the reagents with respect to time 
at a specified concentration (Figure 15).  Take, for instance the slide labeled 
(7SF, 0H, 10-9), (7SF, 4H, 10-9) and (7SF, 8H, 10-9).  This set of slides 
represents a combination of reagents, represented with 7, on a particular 
organism, Streptococcus feacalis (SF), studying the rate of killing with time 
at time interval of 0 h, 4 h and 8 h, respectively at the maximum dilution in-
dex of 10-9.  As it can be observed on the three slides, there is an increase in 
the growth pattern with increasing time from 0 h to 8 h.  After incubation, 
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the slides are counted to determine either the rate of growth or rate of kill-
ing with time. 
D. ANTIMICROBIAL ACTIVITY OF SILVER-TERPENES COMPLEXES 
The minimum inhibitory concentration of various silver-terpenes com-
plexes was determined by agar dilution method as described by the National 
Committee for Clinical Laboratory Standards (1994). Dilution of the plant ex-
tracts ranging from 0.195- 100 mg/mL in Mueller Hinton agar solution were 
prepared by incorporating the extract stock solution into molten agar at 
50oC. After pouring into plates and allowing the agar to set, the plates were 
inoculated with standardized inocula of the test complexes of 105 CFU/mL. 
The plates were further incubated at 37oC for 24 h under aseptic conditions. 
The MICs were the lowest concentrations of the extract resulting in complete 
inhibition of visible growth of the test organisms.   
Table 7: Minimum Inhibitory Concentrations (MICs) of Silver-Terpene 
Complexes 
Complexes   P. vulgaris  S. feacalis  P. aeroginosa  B. cereus 
Ag-camphor  3.125   3.125   3.125    3.125 
Ag-1,8-cineole 0.78125   0.78125   0.78125    0.78125 
Ag-α-pinene  NA    NA    NA     NA  
 
The results of the antimicrobial activity of the complexes of silver with 
various terpenes are shown in Table 7. All the test organisms are observed 
to be sensitive to the both the complexes of camphor and cineole but at dif-
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ferent MICs values.  Silver-camphor complex shows activity at the same MIC 
values on all the test organisms at 3.125 while the silver-cineole complex al-
so showed constant values of MICs of 0.78125 on all the test organisms.  
The MIC for silver-pinene could not be determined due to the unavailability 
of the complex.  The amount obtained was so small to be measured to get 
same amount as obtained for camphor and cineole respectively.  In conclu-
sion, it can be agreed that the silver-cineole showed better MIC results than 
those of silver-camphor. 
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IV. Conclusion 
 The SFME and HD of essential oils of Lavandula officinalis have been re-
viewed and studied. Microwave extraction makes use of the physical and 
chemical phenomenon that is different compared with those applied in con-
ventional isolation techniques. To further add to knowledge, microwave ex-
traction method was found to produce essential oil in concentrate form, free 
from any residual solvents or contaminants. The main component found in 
the Lavandula essential oil was 1,8-cineole, an oxygenated monoterpene 
that has found its usefulness as possessing antiplasmodic and antifungal 
properties. 
 Charge transfer complexation between iodine and α-pinene, 1,8-cineole 
and camphor has been studied, spectrophotometrically and the stability con-
stants determined using the Benesi-Hildebrand equation and also identifying 
various new charge band different from the reactants in question. It was 
concluded that the relative low Kf values obtained suggest that the formed 
complexes are of the weak type, more so, in solution. Kinetics of complex 
formation was also studied to monitor the change in absorption with time.  
The study showed a gradual increase in the rate of absorption with time. 
 The antimicrobial activity of the various pure compounds of essential oil 
in this study, together with the various drugs was well treated. MIC of indi-
vidual reagents were established which was later used to determine their 
combination, one with the other. Interesting results were obtained which will 
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go a long way to further add to existing knowledge.  A particular of interest 
is the MIC for Betadine, a iodine-base compound, adjudged to be highly po-
tent against many strains of bacteria. Further research will be put in place to 
ascertain the true identity of the Betadine, purchased from the local phar-
macy in Alice and several analyses will be done on it, especially in combina-
tion with various pure compounds with the aim of publishing the findings in 
journals.   
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